通痹活络汤联合阿替普酶静脉溶栓治疗急性脑梗死气虚血瘀证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.2;R743.3

基金项目:


Clinical Study on Combination Use of Tongbi Huoluo Decoction and Intravenous Thrombolysis with Alteplase for Acute Cerebral Infarction with Syndrome of Qi Deficiency and Blood Stasis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察通痹活络汤联合阿替普酶静脉溶栓治疗急性脑梗死气虚血瘀证的临床疗效。方法:选 取2021年1月—2023年12月濮阳市中医医院神经内科收治的122例急性脑梗死气虚血瘀证患者,按治疗方法 分为观察组62例和对照组60例。2组均予以基础治疗,在此基础上,对照组加以阿替普酶静脉溶栓治疗,观 察组在对照组基础上联合通痹活络汤治疗,2组均治疗4周,随访3个月。比较2组临床疗效,治疗前后中医证 候积分、神经功能[美国国立卫生研究院卒中量表(NIHSS) 评分]、血流动力学[大脑前动脉(ACA)、大脑中 动脉(MCA) 及大脑后动脉(PCA) 的平均血流速度(Vm)] 变化,记录2组随访3个月时预后情况[Barthel 指数(BI) ]。结果:治疗后,观察组总有效率98.39%(61/62),高于对照组86.67%(52/60)(P<0.05)。治疗 后,2组中医证候积分、NIHSS评分均较治疗前降低(P<0.05),观察组中医证候积分、NIHSS评分均低于对 照组(P<0.05);2组ACA、MCA及PCA的Vm均较治疗前加快(P<0.05),观察组ACA、MCA及PCA的Vm 快于对照组(P<0.05)。随访3个月,观察组BI高于对照组(P<0.05)。结论:通痹活络汤联合阿替普酶静脉 溶栓治疗急性脑梗死气虚血瘀证临床疗效好,可缓解临床症状,改善脑动脉血流灌注,促进其神经功能恢复及 预后改善。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the combination use of Tongbi Huoluo Decoction and intravenous thrombolysis with Alteplase on acute cerebral infarction with syndrome of qi deficiency and blood stasis. Methods:A total of 122 patients with acute cerebral infarction with syndrome of qi deficiency and blood stasis admitted to the Department of Neurology, Chinese Medicine Hospital of Puyang from January 2021 to December 2023 were selected and divided into the observation group (62 cases) and the control group (60 cases) according to the treatment method. Both groups were given basic therapy. The control group was additionally treated with intravenous thrombolysis with Alteplase,and the observation group was additionally treated with Tongbi Huoluo Decoction based on the treatment in the control group. Both groups were treated for four weeks and followed up for three months. The clinical effects,and the changes before and after treatment in traditional Chinese medicine syndrome scores,neurological function [scores of National Institutes of Health Stroke Scale (NIHSS)], hemodynamics [mean blood flow velocity (Vm) of anterior cerebral artery( ACA),middle cerebral artery( MCA) and posterior cerebral artery( PCA)] were compared between the two groups;the prognosis in the two groups at the third months of follow-up [Barthel Index(BI)] was recorded. Results: After treatment,the total effective rate was 98.39% (61/62) in the observation group,which was higher than that of 86.67%( 52/60) in the control group( P<0.05). After treatment,the traditional Chinese medicine syndrome scores and NIHSS scores in the two groups were decreased when compared with those before treatment (P<0.05),and the above scores in the observation group were lower than those in the control group (P<0.05). The Vm of ACA,MCA and PCA in the two groups was elevated when compared with that before treatment (P<0.05),and the Vm of ACA,MCA and PCA in the observation group was faster than that in the control group (P<0.05). After three months of follow-up,BI in the observation group was higher than that in the control group (P<0.05). Conclusion:The combination use of Tongbi Huoluo Decoction and intravenous thrombolysis with Alteplase has a great clinical effect on acute cerebral infarction with syndrome of qi deficiency and blood stasis,which can relieve clinical symptoms and improve cerebral artery blood flow perfusion, and promote the recovery of neurological function and improvements in prognosis.

    参考文献
    相似文献
    引证文献
引用本文

贺时磊,王珊珊,李昌明,刘学昌.通痹活络汤联合阿替普酶静脉溶栓治疗急性脑梗死气虚血瘀证临床研究[J].新中医,2025,57(15):74-78

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-08-11
  • 出版日期:
文章二维码